Filter Criteria
Epic:	Keywords:
From:	Time: (hh:mm)	RNS: MonAM:
To:	Time: (hh:mm)

Please Note - Streaming News is only available to subscribers to the Active Level and above

IN BRIEF: MaxCyte chief scientific officer leaves firm

ALN

MaxCyte Inc - Maryland, US-based provider of cell engineering platform technologies developing ‘next-generation cell therapeutics’ - Announces departure of Cenk Sumen as chief scientific officer, but he will remain on advisory board.

Current stock price: 397.50 pence, flat

12-month change: down 14%

Stockwatch	Level 2	Portfolio	Charts	Research	Share Price	Awards	Indices	Market Scan	Company Zone	Traders' Room
Funds	Trades	Terminal	Alerts	Heatmaps	News	Stock Screener	Forward Diary	Forex Prices	Director Deals	Investors' Room
CFDs	Shares	SIPPs	ISAs	Forex	ETFs	Videos	Comparison Tables	Spread Betting	Broker Notes	Shares Magazine

Stockwatch	Level 2	Portfolio	Charts	Research	Share Price	Awards	Indices	Market Scan	Company Zone	Traders' Room
Funds	Trades	Terminal	Alerts	Heatmaps	News	Stock Screener	Forward Diary	Forex Prices	Director Deals	Investors' Room
CFDs	Shares	SIPPs	ISAs	Forex	ETF	Videos	Comparison Tables	Spread Betting	Broker Notes	Shares Magazine